November 2005

J Psychiatry Neurosci 2005;30(6)


Cardiac risk and schizophrenia
R. Jindal, E.M. MacKenzie, G.B. Baker, V.K. Yeragani

Review papers

Dissecting the suicide phenotype: the role of impulsive–aggressive behaviours
G. Turecki

Augmentation of olanzapine in treatment-resistant schizophrenia
M. Zink

Research Papers • Articles de recherche

Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert’s syndrome)
R. Yasukawa, T. Miyaoka, S. Mizuno, T. Inagaki, J. Horiguchi, K. Oda, H. Kitagaki

Long-term lithium treatment and thyroid antibodies: a controlled study
C. Baethge, H. Blumentritt, A. Berghöfer, T. Bschor, T. Glenn, M. Adli, P. Schlattmann, M. Bauer, R. Finke

Brief reports

Ziprasidone therapy for post-traumatic stress disorder
Z. Siddiqui, W.A. Marcil, S.C. Bhatia, S. Ramaswamy, F. Petty

Modafinil as an adjunctive treatment to sleep deprivation in depression
C. Even, J. Thuile, J. Santos, P. Bourgin

Letters to the Editors

Repetitive transcranial magnetic stimulation for the treatment of depression
F. Fregni, A. Pascual-Leone

Response from author
J. Couturier

CCNP News and Views

The 28th Annual Meeting of the Canadian College of Neuropsychopharmacology
St. John’s, Newfoundland, Canada, July 2–5, 2005

K. Casey, L.K. Srivastava, C. Flores, M. Leyton

Psychopharmacology for the Clinician

What is the role of pharmacotherapy in the treatment of anorexia nervosa?
M. Israël